Shin, Seung-Shick
Jeong, Byeong-Seon
Wall, Brian A.
Li, Jiadong
Shan, Naing Lin
Wen, Yu
Goydos, James S.
Chen, Suzie
Funding for this research was provided by:
Foundation for the National Institutes of Health (RO1CA124975, R21CA139473)
Article History
Received: 10 October 2018
Accepted: 24 October 2018
First Online: 14 November 2018
Conflict of interest
: Drs. Chen and Goydos have a part in the joint license of riluzole for treating various forms of cancer with Biohaven. The remaining authors declare that they have no conflict of interest.